Please activate JavaScript!
Please install Adobe Flash Player, click here for download
ePaper created 2017-12-05, 09:23:08 | version 1.38.0
I industry _ Neoss Neoss: A proven heritage Author_Neoss Staff _Convinced that existing implant systems were too complex, Professor Neil Meredith and Fredrik Engman founded Neoss in 2000 with the idea to create a much simpler and more ration- alized solution. According to the company, the benefits of the resulting products are clear: re- duced patient treatment time, optimized inven- tory control and superior outcomes for patients. _Proven clinical evidence and design of Neoss Implants Produced with commercially pure titanium (Grade IV), ProActive Implants have a low surface roughness flange designed to reduce marginal bone loss.1 At the same time, higher surface roughness of the threaded body of the implants optimizes stability and osseointegration. The universal Thread Cutting and Forming (TCF) design of the implant ensures suitability for all bone qualities. The secondary cutting face provides additional efficiency in dense bone.2 Threads extend to the tip of the implant ensuring excellent stability. _Proven clinical experience A randomly selected population of 100,000 implants was sampled from the Neoss war- ranty registry, and statistical analysis indi- cated a three-year cumulative survival rate of 98.2 percent. Of the 1.8 percent of failures, the major aetiological factors were smoking, a com- bination of poor bone quality, bone quantity and immediate loading.3 _Features of the Neoss ProActive Surface Surface roughness and hydrophilicity are es- sential to the absorption of proteins and biomol- ecules onto implant surfaces, thereby facilitating healing and bone formation.4 Neoss has utilized Electrowetting on titanium surfaces to increase hydrophilicity and maximize the penetration of blood and its components onto the implant surface. The etched, blasted and treated Pro-Active Implant surface stimulates bone to form more rapidly and with a greater strength at the implant interface.5 ProActive Implants surpassed the per- formance of competitive implants in in-vivo removal torque tests.6 In the first published study of ProActive Im- plants, they recorded a 100 percent success rate after one year of placement in non-bone grafted patients and 98.5 percent in bone-augmented patients.7 In the same study group of patients, marginal bone loss of 0.4 mm was recorded at one year.8 Studies have consistently shown outstanding survival rates and retention of marginal bone levels. With five implant diameters, two implant de- signs and just one connection, the Neoss Implant system provides both surgeons and restorative dentists the greatest possible freedom and flex- ibility without compromise in performance or success, according to the company. All prosthetic components in the Neoss System are compatible with ProActive Straight and ProActive Tapered implants. _NeoLoc connection NeoLoc® is the unique Neoss implant to abut- ment connection that offers the advantages of a remarkably strong and tight connection, proven long-term clinical success, high levels of bone preservation, optimal flexibility for restoration and the “one connection” concept, the company asserts. Neoss engaging abutments have defor- mation lugs that minimize rotational movements and secure a distinct seating. CrystalocTM abutment screws are 30 percent stronger than gold screws in static strength testing, thus facilitating a high clamping force between the abutment and implant,8 offering an additional 10 percent resistance to fracture dur- ing long-term clinical function.9 Warranty data over many years has demon- strated a low fracture rate with less than one fractured implant per 10,000 implants.10 For more information, contact Neoss Inc., at (866) 626-3677 or usa@neoss.com._ * References available upon request from the publisher. (Photos/Provided by Neoss) 18 I implants 4_2017